ADHERIUM LIMITED - Announcements

Market Cap $13.14M Add to my watchlist

Healthcare Medical Devices

Adherium Limited is a New Zealand-based international respiratory e-health company. The... Adherium Limited is a New Zealand-based international respiratory e-health company. The Company is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Company’s Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Company’s technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.More

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

ADR	AstraZeneca selected Adherium Smartinhaler for its study	PRICE SENSITIVE	24/05/24	150.52KB	Share
ADR	Non-Renounceable Rights Issue Offer Completes	PRICE SENSITIVE	23/05/24	109.84KB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/24	387.88KB	Share
ADR	Prospectus	PRICE SENSITIVE	26/04/24	528.7KB	Share
ADR	Placement and Entitlement Offer to raise up to $8.37 million	PRICE SENSITIVE	26/04/24	194.09KB	Share
ADR	Trading Halt	PRICE SENSITIVE	23/04/24	145.77KB	Share
ADR	First Patient Enrolled in Major e-health Clinical Study	PRICE SENSITIVE	20/03/24	135.26KB	Share
ADR	Adherium receives $1.5m Australian R&D Tax Rebate	PRICE SENSITIVE	07/03/24	114.29KB	Share
ADR	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/24	5.94MB	Share
ADR	New CEO Appointed - Dr Paul Mastoridis	PRICE SENSITIVE	01/02/24	154.55KB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	310.32KB	Share
ADR	Resignation of CEO	PRICE SENSITIVE	16/01/24	111.47KB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	344.77KB	Share
ADR	Notice of Annual General Meeting/Proxy Form	PRICE SENSITIVE	26/10/23	502.15KB	Share
ADR	Annual Report to shareholders	PRICE SENSITIVE	30/08/23	7.07MB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/23	321.06KB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/04/23	390.85KB	Share
ADR	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/23	4.27MB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/23	390.91KB	Share
ADR	Adherium SPP and Shortfall Offers Prospectus	PRICE SENSITIVE	17/11/22	1.12MB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/22	458.8KB	Share
ADR	Annual Report to shareholders	PRICE SENSITIVE	30/09/22	5.39MB	Share
ADR	Adherium secures $13.5m in placement commitments	PRICE SENSITIVE	16/09/22	213.58KB	Share
ADR	Trading Halt	PRICE SENSITIVE	14/09/22	286.44KB	Share
ADR	Preliminary Final Report	PRICE SENSITIVE	31/08/22	435.17KB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/22	501.89KB	Share
ADR	Adherium signs UK distribution agreement with Helicon Health	PRICE SENSITIVE	14/06/22	110.14KB	Share
ADR	Adherium to support Avillion sponsored clinical study	PRICE SENSITIVE	02/06/22	135.98KB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/22	341.01KB	Share
ADR	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/22	5.15MB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/01/22	452.88KB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/21	517.73KB	Share
ADR	Adherium awarded US-based AZ clinical study supply contract	PRICE SENSITIVE	24/09/21	111.5KB	Share
ADR	Preliminary Final Report	PRICE SENSITIVE	27/08/21	431.33KB	Share
ADR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/21	493.8KB	Share
ADR	Target's Statement	PRICE SENSITIVE	28/06/21	9.29MB	Share
ADR	Letter to Shareholders re takeover offer	PRICE SENSITIVE	17/06/21	132.62KB	Share
ADR	Adherium submits next gen sensor for US FDA clearance	PRICE SENSITIVE	01/06/21	141.02KB	Share
ADR	RSH: Replacement Bidders Statement	PRICE SENSITIVE	27/05/21	2.47MB	Share
ADR	RSH: 1st Supplementary Bidder's Statement(marked up replac	PRICE SENSITIVE	27/05/21	2.7MB	Share
ADR	Adherium announces new CEO and Board appointments	PRICE SENSITIVE	13/05/21	218.9KB	Share
ADR	Adherium Directors' Statement re Takeover	PRICE SENSITIVE	10/05/21	138.41KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/21	501.05KB	Share
ADR	Adherium response to Respiri announcement	PRICE SENSITIVE	30/04/21	169.84KB	Share
ADR	RSH: Bidder's Statement	PRICE SENSITIVE	29/04/21	2.02MB	Share
ADR	Adherium investor presentation	PRICE SENSITIVE	18/03/21	12.37MB	Share
ADR	Adherium secures $18m share placement commitment	PRICE SENSITIVE	18/03/21	152.83KB	Share
ADR	Trading Halt	PRICE SENSITIVE	16/03/21	287.35KB	Share
ADR	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	961.61KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/21	1.24MB	Share
ADR	Adherium agrees rollout to specialist US respiratory centres	PRICE SENSITIVE	24/11/20	139.25KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/20	535.1KB	Share
ADR	Adherium secures $3m funding from Viburnum	PRICE SENSITIVE	26/10/20	137.46KB	Share
ADR	Preliminary Final Report	PRICE SENSITIVE	28/08/20	316.64KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/20	369.09KB	Share
ADR	CEO update presentation to the EGM	PRICE SENSITIVE	24/07/20	842.25KB	Share
ADR	Adherium $5m raise with BioScience Managers Translation Fund	PRICE SENSITIVE	26/05/20	140.11KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/20	378.09KB	Share
ADR	Adherium progresses US sales agreement with Monaghan Medical	PRICE SENSITIVE	29/04/20	140.12KB	Share
ADR	Adherium appoints Mike Motion CEO/Director and Anne Bell CFO	PRICE SENSITIVE	24/04/20	189.07KB	Share
ADR	Adherium and Planet Innovation partner in tech development	PRICE SENSITIVE	21/04/20	134.37KB	Share
ADR	Adherium announces collaboration with HGE Health in COPD	PRICE SENSITIVE	16/04/20	143.16KB	Share
ADR	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/20	1.16MB	Share
ADR	Adherium Completes $5.4m Capital Raise	PRICE SENSITIVE	11/02/20	141.63KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/20	380.95KB	Share
ADR	Adherium December 2019 Update Presentation	PRICE SENSITIVE	19/12/19	1.79MB	Share
ADR	Adherium Non-renounceable Rights Issue Offer Document	PRICE SENSITIVE	19/12/19	784KB	Share
ADR	Adherium announces Non-Renounceable Issue	PRICE SENSITIVE	11/12/19	165.23KB	Share
ADR	Adherium appoints Peter Stratford CEO and Mike Motion CCO	PRICE SENSITIVE	22/11/19	172.4KB	Share
ADR	Adherium and Patients Know Best strategic collaboration	PRICE SENSITIVE	18/11/19	130.93KB	Share
ADR	Amended - Adherium announces $1.1m notes financing	PRICE SENSITIVE	11/11/19	326.29KB	Share
ADR	Response to ASX Query	PRICE SENSITIVE	11/11/19	641.51KB	Share
ADR	Adherium announces $1.2m second round notes financing	PRICE SENSITIVE	11/11/19	163.09KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/19	547.81KB	Share
ADR	Preliminary Final Report	PRICE SENSITIVE	30/08/19	402.24KB	Share
ADR	Adherium announces $1.8m secured notes financing	PRICE SENSITIVE	22/08/19	247.67KB	Share
ADR	Adherium and Summatix announce strategic initiative	PRICE SENSITIVE	20/08/19	165.19KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/19	498.73KB	Share
ADR	Adherium Receives further U.S. 510k Clearances	PRICE SENSITIVE	15/07/19	155.44KB	Share
ADR	Employee Share Plan buy-back - Appendix 3C	PRICE SENSITIVE	24/05/19	226.44KB	Share
ADR	Response to Appendix 4C Query	PRICE SENSITIVE	07/05/19	566.1KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/19	413.4KB	Share
ADR	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/19	9.14MB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/19	417.37KB	Share
ADR	Adherium Restructures for Growth	PRICE SENSITIVE	13/12/18	138.74KB	Share
ADR	Adherium Investor Conference Call Presentation	PRICE SENSITIVE	31/10/18	12.5MB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/18	418.29KB	Share
ADR	Adherium Investor Conference Call Presentation	PRICE SENSITIVE	28/08/18	1.45MB	Share
ADR	Preliminary Final Report	PRICE SENSITIVE	28/08/18	409.47KB	Share
ADR	Adherium and Vitalus Health Launch Commercial Program	PRICE SENSITIVE	23/08/18	192.08KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/18	496.44KB	Share
ADR	Adherium Receives Additional US FDA 510(k) Clearance	PRICE SENSITIVE	27/07/18	190.42KB	Share
ADR	Adherium Program with Connecticut Childrens Medical Center	PRICE SENSITIVE	10/07/18	175.6KB	Share
ADR	Adherium Smartinhaler used in Global Mild-Asthma Studies	PRICE SENSITIVE	21/05/18	223.17KB	Share
ADR	Adherium launches new global brand Hailie	PRICE SENSITIVE	17/05/18	172.13KB	Share
ADR	Adherium Announces Program with Vitalus Health	PRICE SENSITIVE	01/05/18	53.9KB	Share
ADR	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/18	507.22KB	Share
ADR	Employee Share Plan buy-back - Appendix 3C	PRICE SENSITIVE	24/04/18	268.08KB	Share
ADR	Adherium receives US FDA 510k OTC clearance	PRICE SENSITIVE	27/03/18	183.45KB	Share
ADR	Response to ASX Query	PRICE SENSITIVE	22/03/18	487.47KB	Share

ADR AstraZeneca selected Adherium Smartinhaler for its study
24/05/24	PRICE SENSITIVE	150.52KB	Share
ADR Non-Renounceable Rights Issue Offer Completes
23/05/24	PRICE SENSITIVE	109.84KB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
29/04/24	PRICE SENSITIVE	387.88KB	Share
ADR Prospectus
26/04/24	PRICE SENSITIVE	528.7KB	Share
ADR Placement and Entitlement Offer to raise up to $8.37 million
26/04/24	PRICE SENSITIVE	194.09KB	Share
ADR Trading Halt
23/04/24	PRICE SENSITIVE	145.77KB	Share
ADR First Patient Enrolled in Major e-health Clinical Study
20/03/24	PRICE SENSITIVE	135.26KB	Share
ADR Adherium receives $1.5m Australian R&D Tax Rebate
07/03/24	PRICE SENSITIVE	114.29KB	Share
ADR Half Yearly Report and Accounts
29/02/24	PRICE SENSITIVE	5.94MB	Share
ADR New CEO Appointed - Dr Paul Mastoridis
01/02/24	PRICE SENSITIVE	154.55KB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	310.32KB	Share
ADR Resignation of CEO
16/01/24	PRICE SENSITIVE	111.47KB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	344.77KB	Share
ADR Notice of Annual General Meeting/Proxy Form
26/10/23	PRICE SENSITIVE	502.15KB	Share
ADR Annual Report to shareholders
30/08/23	PRICE SENSITIVE	7.07MB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23	PRICE SENSITIVE	321.06KB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
27/04/23	PRICE SENSITIVE	390.85KB	Share
ADR Half Yearly Report and Accounts
27/02/23	PRICE SENSITIVE	4.27MB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
30/01/23	PRICE SENSITIVE	390.91KB	Share
ADR Adherium SPP and Shortfall Offers Prospectus
17/11/22	PRICE SENSITIVE	1.12MB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22	PRICE SENSITIVE	458.8KB	Share
ADR Annual Report to shareholders
30/09/22	PRICE SENSITIVE	5.39MB	Share
ADR Adherium secures $13.5m in placement commitments
16/09/22	PRICE SENSITIVE	213.58KB	Share
ADR Trading Halt
14/09/22	PRICE SENSITIVE	286.44KB	Share
ADR Preliminary Final Report
31/08/22	PRICE SENSITIVE	435.17KB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
28/07/22	PRICE SENSITIVE	501.89KB	Share
ADR Adherium signs UK distribution agreement with Helicon Health
14/06/22	PRICE SENSITIVE	110.14KB	Share
ADR Adherium to support Avillion sponsored clinical study
02/06/22	PRICE SENSITIVE	135.98KB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
29/04/22	PRICE SENSITIVE	341.01KB	Share
ADR Half Yearly Report and Accounts
25/02/22	PRICE SENSITIVE	5.15MB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
28/01/22	PRICE SENSITIVE	452.88KB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
29/10/21	PRICE SENSITIVE	517.73KB	Share
ADR Adherium awarded US-based AZ clinical study supply contract
24/09/21	PRICE SENSITIVE	111.5KB	Share
ADR Preliminary Final Report
27/08/21	PRICE SENSITIVE	431.33KB	Share
ADR Quarterly Activities/Appendix 4C Cash Flow Report
30/07/21	PRICE SENSITIVE	493.8KB	Share
ADR Target's Statement
28/06/21	PRICE SENSITIVE	9.29MB	Share
ADR Letter to Shareholders re takeover offer
17/06/21	PRICE SENSITIVE	132.62KB	Share
ADR Adherium submits next gen sensor for US FDA clearance
01/06/21	PRICE SENSITIVE	141.02KB	Share
ADR RSH: Replacement Bidders Statement
27/05/21	PRICE SENSITIVE	2.47MB	Share
ADR RSH: 1st Supplementary Bidder's Statement(marked up replac
27/05/21	PRICE SENSITIVE	2.7MB	Share
ADR Adherium announces new CEO and Board appointments
13/05/21	PRICE SENSITIVE	218.9KB	Share
ADR Adherium Directors' Statement re Takeover
10/05/21	PRICE SENSITIVE	138.41KB	Share
ADR Appendix 4C - quarterly
30/04/21	PRICE SENSITIVE	501.05KB	Share
ADR Adherium response to Respiri announcement
30/04/21	PRICE SENSITIVE	169.84KB	Share
ADR RSH: Bidder's Statement
29/04/21	PRICE SENSITIVE	2.02MB	Share
ADR Adherium investor presentation
18/03/21	PRICE SENSITIVE	12.37MB	Share
ADR Adherium secures $18m share placement commitment
18/03/21	PRICE SENSITIVE	152.83KB	Share
ADR Trading Halt
16/03/21	PRICE SENSITIVE	287.35KB	Share
ADR Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	961.61KB	Share
ADR Appendix 4C - quarterly
29/01/21	PRICE SENSITIVE	1.24MB	Share
ADR Adherium agrees rollout to specialist US respiratory centres
24/11/20	PRICE SENSITIVE	139.25KB	Share
ADR Appendix 4C - quarterly
28/10/20	PRICE SENSITIVE	535.1KB	Share
ADR Adherium secures $3m funding from Viburnum
26/10/20	PRICE SENSITIVE	137.46KB	Share
ADR Preliminary Final Report
28/08/20	PRICE SENSITIVE	316.64KB	Share
ADR Appendix 4C - quarterly
31/07/20	PRICE SENSITIVE	369.09KB	Share
ADR CEO update presentation to the EGM
24/07/20	PRICE SENSITIVE	842.25KB	Share
ADR Adherium $5m raise with BioScience Managers Translation Fund
26/05/20	PRICE SENSITIVE	140.11KB	Share
ADR Appendix 4C - quarterly
30/04/20	PRICE SENSITIVE	378.09KB	Share
ADR Adherium progresses US sales agreement with Monaghan Medical
29/04/20	PRICE SENSITIVE	140.12KB	Share
ADR Adherium appoints Mike Motion CEO/Director and Anne Bell CFO
24/04/20	PRICE SENSITIVE	189.07KB	Share
ADR Adherium and Planet Innovation partner in tech development
21/04/20	PRICE SENSITIVE	134.37KB	Share
ADR Adherium announces collaboration with HGE Health in COPD
16/04/20	PRICE SENSITIVE	143.16KB	Share
ADR Half Yearly Report and Accounts
28/02/20	PRICE SENSITIVE	1.16MB	Share
ADR Adherium Completes $5.4m Capital Raise
11/02/20	PRICE SENSITIVE	141.63KB	Share
ADR Appendix 4C - quarterly
31/01/20	PRICE SENSITIVE	380.95KB	Share
ADR Adherium December 2019 Update Presentation
19/12/19	PRICE SENSITIVE	1.79MB	Share
ADR Adherium Non-renounceable Rights Issue Offer Document
19/12/19	PRICE SENSITIVE	784KB	Share
ADR Adherium announces Non-Renounceable Issue
11/12/19	PRICE SENSITIVE	165.23KB	Share
ADR Adherium appoints Peter Stratford CEO and Mike Motion CCO
22/11/19	PRICE SENSITIVE	172.4KB	Share
ADR Adherium and Patients Know Best strategic collaboration
18/11/19	PRICE SENSITIVE	130.93KB	Share
ADR Amended - Adherium announces $1.1m notes financing
11/11/19	PRICE SENSITIVE	326.29KB	Share
ADR Response to ASX Query
11/11/19	PRICE SENSITIVE	641.51KB	Share
ADR Adherium announces $1.2m second round notes financing
11/11/19	PRICE SENSITIVE	163.09KB	Share
ADR Appendix 4C - quarterly
31/10/19	PRICE SENSITIVE	547.81KB	Share
ADR Preliminary Final Report
30/08/19	PRICE SENSITIVE	402.24KB	Share
ADR Adherium announces $1.8m secured notes financing
22/08/19	PRICE SENSITIVE	247.67KB	Share
ADR Adherium and Summatix announce strategic initiative
20/08/19	PRICE SENSITIVE	165.19KB	Share
ADR Appendix 4C - quarterly
31/07/19	PRICE SENSITIVE	498.73KB	Share
ADR Adherium Receives further U.S. 510k Clearances
15/07/19	PRICE SENSITIVE	155.44KB	Share
ADR Employee Share Plan buy-back - Appendix 3C
24/05/19	PRICE SENSITIVE	226.44KB	Share
ADR Response to Appendix 4C Query
07/05/19	PRICE SENSITIVE	566.1KB	Share
ADR Appendix 4C - quarterly
30/04/19	PRICE SENSITIVE	413.4KB	Share
ADR Half Yearly Report and Accounts
28/02/19	PRICE SENSITIVE	9.14MB	Share
ADR Appendix 4C - quarterly
31/01/19	PRICE SENSITIVE	417.37KB	Share
ADR Adherium Restructures for Growth
13/12/18	PRICE SENSITIVE	138.74KB	Share
ADR Adherium Investor Conference Call Presentation
31/10/18	PRICE SENSITIVE	12.5MB	Share
ADR Appendix 4C - quarterly
31/10/18	PRICE SENSITIVE	418.29KB	Share
ADR Adherium Investor Conference Call Presentation
28/08/18	PRICE SENSITIVE	1.45MB	Share
ADR Preliminary Final Report
28/08/18	PRICE SENSITIVE	409.47KB	Share
ADR Adherium and Vitalus Health Launch Commercial Program
23/08/18	PRICE SENSITIVE	192.08KB	Share
ADR Appendix 4C - quarterly
31/07/18	PRICE SENSITIVE	496.44KB	Share
ADR Adherium Receives Additional US FDA 510(k) Clearance
27/07/18	PRICE SENSITIVE	190.42KB	Share
ADR Adherium Program with Connecticut Childrens Medical Center
10/07/18	PRICE SENSITIVE	175.6KB	Share
ADR Adherium Smartinhaler used in Global Mild-Asthma Studies
21/05/18	PRICE SENSITIVE	223.17KB	Share
ADR Adherium launches new global brand Hailie
17/05/18	PRICE SENSITIVE	172.13KB	Share
ADR Adherium Announces Program with Vitalus Health
01/05/18	PRICE SENSITIVE	53.9KB	Share
ADR Appendix 4C - quarterly
30/04/18	PRICE SENSITIVE	507.22KB	Share
ADR Employee Share Plan buy-back - Appendix 3C
24/04/18	PRICE SENSITIVE	268.08KB	Share
ADR Adherium receives US FDA 510k OTC clearance
27/03/18	PRICE SENSITIVE	183.45KB	Share
ADR Response to ASX Query
22/03/18	PRICE SENSITIVE	487.47KB	Share

REFRESH

(20min delay)
Last 1.8¢		Change -0.001(5.26%)		Mkt cap ! $13.14M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.8¢	$35.56K	1.962M

Buyers (Bids)

No.	Vol.	Price($)
7	457313	1.7¢

Sellers (Offers)

Price($)	Vol.	No.
1.8¢	326451	2

View Market Depth

No.	Vol.	Price($)
7	457313	0.017
10	1010562	0.016
6	916665	0.015
3	360428	0.014
1	600000	0.013

Price($)	Vol.	No.
0.018	106451	1
0.019	708772	6
0.020	755559	3
0.021	837666	2
0.022	75499	2

Last trade - 14.58pm 28/05/2024 (20 minute delay)


Last 1.8¢		Change -0.001 ( 2.70 %)
Open	High	Low	Volume
1.9¢	1.9¢	1.8¢	978625
Last updated 14.58pm 28/05/2024 ?

ADR (ASX) Chart

ADHERIUM LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories